Spots Global Cancer Trial Database for Reducing UV Exposure to Prevent Skin Cancer: Message Development & Testing
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Reducing UV Exposure to Prevent Skin Cancer: Message Development & Testing
Official Title: Reducing UV Exposure to Prevent Skin Cancer: Message Development & Testing
Study ID: NCT03201120
Conditions
Study Description
Brief Summary: Phase 3b of the research will be a laboratory experiment that uses an experimental and analytic design that is parallel to that used in Phase 3a, the online experiment. The primary objective of Phase 3b is to assess physiological response (i.e., eye tracking) to different message appeals of the audio-visual messages used in Phase 3a on respondents' behavioral intentions and UV-related behavioral choices post-exposure. Including time for preparation, viewing, and removal of the monitoring equipment, the message viewing session will take about 45 minutes per session.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: ALL
Healthy Volunteers: No
Locations
CIRNA Lab, Philadelphia, Pennsylvania, United States
Contact Details
Name: Karen Glanz, PhD, MPH
Affiliation: University of Pennsylvania
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
